In this guide
What is MSM (Methylsulfonylmethane)?
MSM is an organosulfur supplement studied mainly for knee symptoms. Trials are small, use different daily totals and do not establish cartilage repair. No U.S. RDA, AI, UL or established osteoarthritis treatment dose exists for MSM. Trial totals from 1.5 to 6 g/day are source-specific, not a dose ladder. [1]
Typical MSM (Methylsulfonylmethane) Protocols
| Source and population | Form and amount each time | Frequency | Total exposure | Duration or boundary |
|---|---|---|---|---|
| Debbi 2011 · 49 adults with radiographic knee OA | MSM 1.125 g per administration | Three times daily | 3.375 g/day | 12 weeks; small function/total-score differences |
| Kim 2006 · 50 adults with knee OA pain | MSM 3 g per administration | Twice daily | 6 g/day | 12 weeks; pilot pain/function outcomes |
| Toguchi 2023 · 88 healthy adults with mild knee pain | Ten tablets, 200 mg MSM each, across the day | Daily distribution not specified in abstract | 2 g/day | 12 weeks; sponsor-employed investigators |
These rows reproduce sources. Do not average them into one universal regimen.
From source to outcome
3.375 g/day in Debbi.
Clinical importance uncertain.
Track pain and function.
Which forms and label details matter?
Record methylsulfonylmethane active grams, amount each time, frequency, powder or capsule, and co-ingredients such as glucosamine or boswellia. DMSO and MSM are related but not interchangeable.
How should it be stored?
Follow the label, close the container and protect it from heat, light and moisture.
Read the label before the claim
Keep the tested preparation.
Do not infer a universal regimen.
Appearance is not disease treatment.
What is it commonly used for?
MSM is marketed for knee pain, inflammation, recovery, skin and “detox.” Direct human evidence centers on short knee-symptom trials; detox and cartilage-regrowth claims are not established.
What does human research show?
Debbi enrolled 49 adults with radiographic knee osteoarthritis and used 1.125 g three times daily for 12 weeks. WOMAC physical function and total score differed over time, while WOMAC pain and stiffness and secondary outcomes did not clearly differ; the authors questioned clinical significance. [2] Kim’s 50-person pilot used 3 g twice daily for 12 weeks and reported selected pain and function improvements, but could not establish long-term benefit or safety. [3] Toguchi randomized 88 healthy adults with mild knee pain to 2 g/day or placebo for 12 weeks and reported a borderline primary JKOM difference; all first three authors worked for the product company. [4] A meta-analysis found only one eligible MSM trial among three included DMSO/MSM studies and concluded evidence was not definitive. [5]

How might it act?
MSM contributes sulfur and changes inflammatory or oxidative markers in experimental systems. These mechanisms do not prove analgesia, cartilage repair, “detoxification” or improved recovery in humans.
How does it compare with related products?
| Product | Identity to preserve | Evidence boundary |
|---|---|---|
| Collagen | Source, hydrolysis and peptide grams | Skin findings are sensitive to funding and study quality |
| Hyaluronic acid | Hyaluronan mass and molecular weight | Small product-linked oral trials |
| Keratin | Hydrolysate source and co-ingredients | Finished-product evidence cannot isolate generic keratin |
| Astaxanthin | Natural or synthetic source and active mg | Small skin trials do not establish disease prevention |
What are the risks and interactions?
GI upset, headache, insomnia, rash and allergy can occur. Long-term and pregnancy/breastfeeding data are limited. Review anticoagulants, diabetes medicines, surgery and co-ingredient exposure; do not delay evaluation of a hot, swollen or injured joint.
Which medicines require review?
Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.
Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [1], [6]
What should be monitored?
Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.
What happens when it is stopped?
No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.
Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.
What do public communities report?
Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.
Common questions about MSM (Methylsulfonylmethane)
Does MSM rebuild cartilage?
No human trial establishes cartilage regeneration.
Is 6 g/day the standard dose?
No. It was one pilot-trial schedule, not an established treatment dose.
Can I take the daily total at once?
Do not infer that. Debbi used three administrations and Kim used two.
What about MSM plus glucosamine?
A combination trial cannot show which ingredient caused a result.
Is MSM the same as DMSO?
No. They are related sulfur compounds with different products and evidence.
What should I track?
Amount each time, frequency, total, co-ingredients, pain/function score, adverse effects and review date.
Glossary
Terms for reading the evidence.
- Active amount
- The declared amount of the studied ingredient, distinct from total blend mass.
- Formulation
- Source, processing, molecular size and co-ingredients that define the tested product.
- Randomized controlled trial
- A study assigning participants to intervention or comparator by chance.
- Funding sensitivity
- A result pattern that changes when studies are grouped by sponsor support.
- Endpoint
- The prespecified measurement used to judge a study result.
- Generalizability
- How well a result applies beyond the exact study product and population.
How this guide was researched
Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.
Explore the sources
Sources preserve form, amount, frequency, population, duration and outcome.
Showing 6 sources
- 01
Questions and Answers on Dietary Supplements ↗
Official regulatory overview
Current page or report reviewed; scope and limits retained.
Detail: Finished-product and claim boundaries.
- 02
Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. ↗
Randomized knee-OA trial
Current page or report reviewed; scope and limits retained.
Detail: 49 enrolled; 1.125 g three times daily; mixed outcomes.
- 03
Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. ↗
Randomized pilot trial
Current page or report reviewed; scope and limits retained.
Detail: 50 adults; 3 g twice daily for 12 weeks.
- 04
Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. ↗
Randomized mild-pain trial
Current page or report reviewed; scope and limits retained.
Detail: 88 adults; 2 g/day; product-company affiliations.
- 05
Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. ↗
Systematic review and meta-analysis
Current page or report reviewed; scope and limits retained.
Detail: Sparse and heterogeneous DMSO/MSM trial evidence.
- 06
Product Licensing ↗
Canadian licensing overview
Current page or report reviewed; scope and limits retained.
Detail: Finished natural health products require licensing and authorized labels.
No matching sources
Try a different term or show the full list.